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Introduction {#s0005}
============

Exposure to airborne particulate matter with aerodynamic diameter less than 2.5 μm (PM~2.5~) has been epidemiologically associated with respiratory diseases [@b0005], [@b0010]. Harmful PM~2.5~ pollutants are released into the pulmonary surfactant and then attached to pulmonary epithelial cells [@b0010]. Thus, it can increase the risk of multiple airway illnesses, including chronic obstructive pulmonary disease (COPD) [@b0015], bronchitis [@b0020], asthma [@b0025], and idiopathic pulmonary fibrosis (IPF) [@b0030]. Pulmonary fibrosis is characterized by excessive deposition of collagen in the lungs, leading to chronically impaired gas exchange and death [@b0030]. It has been verified that PM~2.5~ and PM~10~ exposure accelerates functional decline in IPF patients determined by linear multivariable mixed-effects model [@b0035].

Inflammatory responses [@b0040], [@b0045], immune cell activation [@b0045], [@b0050], [@b0055], and oxidative stress [@b0060], [@b0065] are highly associated with pulmonary fibrosis pathogenesis. Oropharyngeal aspiration of PM~2.5~ induces significant collagen deposition and increases in the levels of the inflammatory markers interleukin 1-β (IL-1β) and transforming growth factor (TGF-β1), in mouse lungs after 21 days of treatment [@b0040]. Anti-inflammatory cytokine IL-13 mediates fibrogenesis by regulating TGF-β1 expression and recruiting leukocytes into the lesion site [@b0045]. Tumor necrosis factor-α (TNF-α) can also activate macrophages to secrete TGF-β1, leading to extracellular matrix (ECM) deposition [@b0055]. In addition, high levels of oxidant stress have been detected in IPF patients compared with controls [@b0070], and oxidant--antioxidant imbalances in the lower respiratory tract are strongly associated with IPF pathogenesis [@b0060]. A recent study has unraveled that exposure to PM~2.5~ promotes fibrotic response by increasing the expression of Col1a1, Col3a1, Cox-4, and TGF-β1, activating *smad3* expression, as well as generating reactive oxygen species (ROS) [@b0075]. These findings further support the critical role of oxidative stress in fibrogenesis.

Epigenetic mechanisms, especially aberrant transcriptome induced by altered DNA methylation, have been shown to be associated with PM~2.5~ exposure and possible pathogenesis [@b0080], [@b0085]. RNA methylation, another epigenetic mechanism that regulates gene expression, has been shown to participate in various disease processes [@b0090]. For example, as the most abundant internal RNA modification, *N*^6^-methyladenosine (m^6^A) is involved in acute myelocytic leukemia (AML), metabolic disorders, and nervous system disorders [@b0090]. 5-Methylcytosine (m^5^C) is another prevalent RNA modification in mammals [@b0095], [@b0100] and plants [@b0105], [@b0110]. m^5^C modification is catalyzed by NOP2/Sun RNA methyltransferase family member 2 (NSUN2) in humans, mice, and human immunodeficiency viruses (HIV) [@b0095], [@b0100], [@b0115], [@b0120], [@b0125], [@b0130]. NUSN2 has been shown to mediate RNA transport by m^5^C reader of the nuclear protein Aly/REF export factor (ALYREF) [@b0100], [@b0135]. m^5^C participates in the regulation of RNA processing [@b0120], [@b0140], RNA stability [@b0145], [@b0150], [@b0155], [@b0160], and translation [@b0165], [@b0170]. Moreover, it plays critical roles in several important biological pathways in mice and plants [@b0095], [@b0110]. Recent advances in high-throughput sequencing technologies have facilitated m^5^C site identification at single-base resolutions [@b0095], [@b0100], [@b0110], [@b0115]. These findings suggest that m^5^C modification serves as a key posttranscriptional regulatory factor. However, whether the m^5^C methylome is altered upon PM~2.5~ exposure and further participates in the pathogenesis of pulmonary fibrogenesis is not well understood.

In our previous study, we have uncovered that PM~2.5~ directly affects macrophage polarization and induces the expression of the pro-inflammatory cytokines granulocyte--macrophage colony stimulating factor (GM-CSF), TNF-β, IL-1β, and IL-6 in mice [@b0050]. In this study, the m^5^C methylome was profiled in the pathogenesis of lung fibrosis. We identified a possible novel role of altered m^5^C modification in mediating PM~2.5~-induced lung fibrosis through posttranscriptional regulation.

Results and discussion {#s0010}
======================

PM~2.5~ exposure leads to pulmonary inflammation and fibrosis {#s0015}
-------------------------------------------------------------

To mimic human exposure as accurately as possible, mice were maintained in ambient airborne PM~2.5~ chamber ([Table S1](#s0095){ref-type="sec"}). As shown in [Figure 1](#f0005){ref-type="fig"}A, the weekly average PM~2.5~ concentrations during the exposure period varied from 35.66 μg/m^3^ to 101.60 μg/m^3^. The mean airborne PM~2.5~ concentration to which the mice were exposed during the study period was ∼59.77 μg/m^3^. Histopathological examination of lung sections using hematoxylin and eosin (H&E) and Masson staining showed that compared to filter air (FA)-exposed mice, PM~2.5~-exposed mice exhibited severe lung injury and fibrosis ([Figure 1](#f0005){ref-type="fig"}B). Exposure caused intense inflammatory cell infiltration and thickened alveolar walls in the lungs ([Figure 1](#f0005){ref-type="fig"}B, top); it also caused excessive collagen deposition around the bronchi ([Figure 1](#f0005){ref-type="fig"}B, bottom). Moreover, the expression levels of the inflammatory markers *Timp1*, *Tgfb1*, *Jak2*, *Il6*, *Il17a*, and *Il10* were higher in the PM~2.5~-exposed group than control group (*P* \< 0.05, two-sided Wilcoxon and Mann--Whitney tests, [Figure 1](#f0005){ref-type="fig"}C). These results are consistent with previous reports demonstrating that PM~2.5~-induced disorder of inflammatory cytokine networks may lead to the death of lung epithelial cells and fibroblasts [@b0175], [@b0180], [@b0185]. Importantly, we found that PM~2.5~ exposure increased NSUN2 mRNA and protein levels in the lung ([Figure 1](#f0005){ref-type="fig"}D and E). NSUN2 has been shown to methylate a variety of mRNAs and to promote or inhibit cell growth and proliferation [@b0190]. It has been reported that the protein expression of NSUN2 is increased in human breast cancer [@b0195]. As NSUN2 is a well-validated m^5^C methyltransferase [@b0095], [@b0100], [@b0115], [@b0120], [@b0125], it is possible that altered expression of *Nsun2* could disturb basic biological functions by affecting the number or methylation level of m^5^C sites. Thus, we hypothesize that PM~2.5~ may contribute to altered mRNA m^5^C methylomes during pulmonary fibrosis development.Figure 1**PM~2.5~ exposure induced pulmonary inflammation and fibrosisA.** The average daily PM~2.5~ concentrations in the exposure chamber during the study period. **B**. Representative images of H&E and Masson's trichrome staining in lungs of FA- and PM~2.5~-exposed mice. Scale bar = 100 μm. **C.** RT-qPCR analysis showing the relative expression levels (compared to FA) of inflammatory and fibrotic genes in mouse lungs. **D.** The mRNA expression of *Nsun2* in mouse lungs examined by RT-qPCR. **E.** The protein expression of NSUN2 in mouse lungs examined by Western blotting. The *P* values were determined using two-tailed Student's *t*-tests. \*, *P* \< 0.05; \*\*, *P* \< 0.01; \*\*\*, *P* \< 0.01. FA, filtered air; PM~2.5~, particulate matter with an aerodynamic diameter less than 2.5 μm; H&E, hematoxylin and eosin; Timp1, tissue inhibitor of metalloproteinase 1; Tgfb1, transforming growth factor, beta 1; Jak2, Janus kinase 2; Il, interleukin; NSUN, NOL1/NOP2/Sun domain family protein.

PM~2.5~ exposure triggers m^5^C modification in pulmonary fibrosis {#s0020}
------------------------------------------------------------------

To define the potential mechanism of PM~2.5~-induced pulmonary fibrosis, we performed RNA bisulfite sequencing (RNA-BisSeq) and RNA sequencing (RNA-Seq) for the lung samples from FA- or PM~2.5~-exposed mice ([Table S2](#s0095){ref-type="sec"}). We found that the mRNA levels of most *Nsun* family members were upregulated in lung samples from PM~2.5~-exposed group with fold change (FC) \> 1.2 and false positive rate (FDR) \< 9.23E−5. Of all the *Nsuns* members, *Nsun2* showed the highest expression level ([Figure 2](#f0010){ref-type="fig"}A). These results are consistent with the results of Western blot and RT-qPCR analyses ([Figure 1](#f0005){ref-type="fig"}D and E). Similarly, we observed that expression of *Sftpc*, *Lcn2*, *Dbp*, *Mmp9*, *Ace2*, and *Hist1h2ad* was upregulated in PM~2.5~-induced pulmonary fibrosis, whereas expression of *Pink1*, *Jak1*, *Tgfb*, and other nine pulmonary fibrosis-related genes was downregulated ([Figure S1](#s0095){ref-type="sec"}A) [@b0200], [@b0205], [@b0210], [@b0215]. Interestingly, 5/6 of the upregulated genes (*Lcn2*, *Dbp*, *Mmp9*, *Ace2*, and *Hist1h2ad*) had more m^5^C sites when comparing ling samples from PM~2.5~-exposed to those from FA-exposed mice samples. The results support a reasonable speculation that m^5^C probably participates in the regulation of pulmonary fibrosis development.Figure 2**Distribution profile of m^5^C in the lung tissues of FA- and PM2.5-exposed miceA.** Bar chart illustrating the expression levels of NOP2/Sun RNA methyltransferase family protein members in lungs of FA- and PM~2.5~-exposed mice, as examined by RNA-Seq. FDR values calculated using Benjamini--Hochberg method were labeled on top of the genes. **B.** Bar chart showing the numbers of m^5^C sites and m^5^C-modified mRNAs lung samples of FA- and PM~2.5~-exposed mice. **C.** Boxplots showing the overall distributions of mRNA m^5^C levels in lung samples of FA- and PM~2.5~-exposed mice using meRanTK. The *P* values were calculated using two-sided Wilcoxon and Mann--Whitney tests. **D.** IGV tracks displaying the distributions of m^5^C methylation level (in the range of 0.0--1.0) on chromosome 2 in lung samples of FA- and PM~2.5~-exposed mice. FDR, false positive rate; IGV, Integrative Genomics Viewer.

NSUN2 upregulation is probably the main reason for m^5^C alterations. It has been demonstrated that PM~2.5~ can elicit oxidative stress by inducing ROS generation and disrupting intracellular redox balance [@b0085]. Moreover, oxidative stress (H~2~O~2~ exposure) has been shown to increase NSUN2 protein expression [@b0220]. We found that transcription factors (TFs) encoded by 12 genes, including *Egr1*, *Eg*r2, *Hlf*, *Hoxa3*, *Hsf1*, *Hsf2*, *Irf7*, *Max*, *Nfe2*, *Pax6*, *Pparg*, and *Stat4* (*P* \< 0.001, hypergeometric test), can potentially bind to the promoter sequence of *Nsun2* [@b0225]. Expression of these genes was upregulated in PM~2.5~-exposed group (FC \> 1.2, FDR \< 0.05). Thus, we speculate that PM~2.5~ induces oxidative stress and increases expression of TFs, which are involved in the upregulation of *Nsun2* and consequently the increase in m^5^C level. However, how PM~2.5~ induces pulmonary fibrogenesis through modulating NSUN2 and TFs warrants further investigation.

We next compared the m^5^C features between PM~2.5~-exposed and control FA groups. We found consistent m^5^C distribution in different regions and conserved m^5^C motif ([Figure S1](#s0095){ref-type="sec"}B and C). Intriguingly, the numbers of m^5^C sites and modified mRNAs increased markedly in PM~2.5~-treated group; 6370 additional m^5^C sites in 1350 mRNAs were detected in the PM~2.5~-treated group ([Figure 2](#f0010){ref-type="fig"}B). The global methylation level was also increased (*P* = 3.08E−5, two-sided Wilcoxon and Mann--Whitney tests, [Figure 2](#f0010){ref-type="fig"}C). In addition, we examined the number of modified mRNAs among different chromosomes. Almost all the chromosomes underwent m^5^C gain, except mitochondrial and Y chromosomes, most likely due to their shorter genome lengths ([Figure S1](#s0095){ref-type="sec"}D). The Integrative Genomics viewer (IGV) tracks also displayed a wide range of m^5^C gain across the whole chromosome 2 ([Figure 2](#f0010){ref-type="fig"}D). We then identified 2215 mRNAs with m^5^C gain and 865 mRNAs with m^5^C loss in lungs of PM~2.5~-exposed mice compared to those of FA-exposed mice ([Figure 3](#f0015){ref-type="fig"}A). The expression of genes with m^5^C gain was upregulated compared to that of genes with m^5^C loss overall (*P* = 1.04E−6, two-sided Wilcoxon and Mann--Whitney tests, [Figure 3](#f0015){ref-type="fig"}B). To exclude the potential impact caused by gene expression, we compared the coverage of m^5^C-modified genes based on the RNA-BisSeq data for the m^5^C gain and loss groups between lung samples of FA and PM~2.5~-exposed mice RNA-BisSeq ([Figure S2](#s0095){ref-type="sec"}A). High Pearson correlation coefficients between FA- and PM~2.5~-exposed mice for gene coverage were obtained in both the m^5^C gain (*R* = 0.89, *P* \< 2.20E−16) and loss groups (*R* = 0.99, *P* \< 2.20E−16). This result indicates that the m^5^C global changes are not affected by gene expression.Figure 3**mRNA m^5^C gain or loss is associated with aberrant transcriptomeA.** Number of mRNAs with m^5^C gain (red) and loss (dark blue) in lung samples from PM~2.5~-exposed mice, compared to those from FA-exposed mice. The pie chart shows the distributions of m^5^C sites in different genic regions. **B.** Cumulative distribution displaying the expression level change of genes with m^5^C gain (red) and loss (dark blue) from RNA-Seq data in lung samples from PM~2.5~-exposed mice, compared to those from FA-exposed mice. The *P* values were calculated using two-sided Wilcoxon and Mann--Whitney tests and are shown in the bottom-right corner. **C.** Scatter plot showing the distributions of genes with significant RNA abundance changes (FC \> 1.5, FDR \< 0.05) with regard to both m^5^C gain/loss and gene expression levels in lung samples from PM~2.5~-exposed mice, compared to those from FA-exposed mice. The dots in red, pink, blue, and dark blue represent upregulated genes with m^5^C gain, downregulated genes with m^5^C gain, upregulated genes with m^5^C loss and downregulated genes with m^5^C loss, respectively. FC, fold change.

We further identified 12,595 differentially expressed genes (DEGs) in PM~2.5~-exposed group (FC \> 1.2, FDR \< 0.05), including 8964 upregulated DEGs and 3631 downregulated DEGs ([Figure S2](#s0095){ref-type="sec"}B). Functional enrichment analysis showed that these DEGs were highly enriched in cellular metabolic processes, RNA processing, immune responses, anatomical structure morphogenesis, system development, and cell differentiation ([Figure S2](#s0095){ref-type="sec"}C and D). To delineate the impact of mRNA m^5^C on the transcriptome profile in mouse pulmonary fibrosis, we compared the alterations in RNA abundance of gene sets with m^5^C gain or loss. We divided the gene sets into four groups (see details in Materials and methods): upregulated genes with m^5^C gain (*n* = 759), upregulated genes with m^5^C loss (*n* = 233), downregulated genes with m^5^C gain (*n* = 592), and downregulated genes with m^5^C loss (*n* = 289) ([Figure 3](#f0015){ref-type="fig"}C). Importantly, over half of the genes with m^5^C gain exhibited upregulated expression levels (759 out of 1351, 56.18%). We found hundreds of mRNAs whose expression was abundant and probably affected by m^5^C gain or loss in lungs of PM~2.5~-exposed mice. Altogether, m^5^C modification may regulate expression of the modified genes that are associated with the pathogenesis of PM~2.5~-induced pulmonary fibrosis.

m^5^C modification regulates PM~2.5~-induced immune and fibrotic responses {#s0025}
--------------------------------------------------------------------------

To further determine the biological significance of the m^5^C-modified DEGs in the lungs of mice exposed to PM~2.5~, gene ontology (GO) and pathway analyses were carried out. A protein--protein interaction (PPI) network analysis of the proteins encoding these DEGs indicates that both up- and downregulated DEGs are involved in multiple processes ([Figures 4](#f0020){ref-type="fig"} and [S3; Tables S3 and S4](#s0095){ref-type="sec"}). As shown in [Figure 4](#f0020){ref-type="fig"}, for example, upregulated genes with m^5^C gain were enriched in neutrophil migration, granulocyte activation, as well as mRNA splicing and metabolism. In contrast, downregulated genes with m^5^C loss were involved in cancer, cell adhesion regulation, and other processes. These results suggest that PM~2.5~ exposure may regulate mRNA processing in lung lesions, leading to the recruitment and activation of immune cells. In particular, mRNA m^5^C gain negatively affected normal metabolic activity by upregulating expression levels of some genes in the lung. Therefore, we speculate that mRNA m^5^C modification may function as a pivotal factor regulating the pathogenesis of pulmonary fibrosis.Figure 4**GO enrichment map of m^5^C-modifed DEGs**Groups of upregulated genes with m^5^C gain (red), downregulated genes with m^5^C gain (pink), upregulated genes with m^5^C loss (blue), and downregulated genes with m^5^C loss (dark blue) are marked in the network (*P* \< 0.01, hypergeometric test; for details, see [Tables S3 and S4)](#s0095){ref-type="sec"}. The dots in the middle of the network with no functional labels represent genes that participate in multiple biological processes. GO, Gene Ontology; PPI, protein--protein interaction; DEG, differentially expressed gene.

GO enrichment map of these gene sets showed that upregulated genes with m^5^C gain were mainly associated with RNA metabolism, oxidative stress responses, inflammatory responses, and immune system process ([Figure 4](#f0020){ref-type="fig"}). Thus, we selected top 53 upregulated DEGs with m^5^C gain that are highly associated with these processes to explore the potential influence of m^5^C in the lungs of mice with pulmonary fibrosis ([Figure 5](#f0025){ref-type="fig"}A). The IGV tracks of *Adipoq*, *Chi3l1*, *Mmp9*, and *Lcn2* are shown in [Figure 5](#f0025){ref-type="fig"}B as examples of alterations in m^5^C levels and gene expression. The tracks clearly exhibit m^5^C gain sites and the higher expression levels of these genes in PM~2.5~-exposed mice than in FA-exposed mice. Moreover, large changes in RNA abundance mediated by acquisition of m^5^C modifications were associated with pulmonary fibrosis induction ([Figure 5](#f0025){ref-type="fig"}C). Among the important genes selected ([Figure 5](#f0025){ref-type="fig"}A), *Lcn2* and *Mmp9* have been reported to participate in pulmonary fibrosis development [@b0230], [@b0235]. *Chi3l1* plays a major role in inflammation and is a potential target for prevention and treatment [@b0240], whereas *Adipoq* is highly associated with the incidence of COPD [@b0245]. The expression of these four key genes was also validated by RT-qPCR ([Figure 5](#f0025){ref-type="fig"}D).Figure 5**Upregulated DEGs with m^5^C gain were associated with immune and inflammatory responses in pulmonary fibrosisA.** Heatmap illustrating the expression levels of the top 53 upregulated DEGs with m^5^C gain (ranked by FDR) in mouse lungs (FC \> 1.5, FDR \< 0.05). The red asterisks mark the important DEGs with validated functions in oxidative stress responses, inflammatory responses, and immune system processes. **B.** IGV tracks displaying m^5^C and RNA-Seq read distributions in the FA (blue) and PM~2.5~-exposed (watermelon red) samples (from left to right: *Adipoq*, *Chi3l1*, *Mmp9*, and *Lcn2*). **C.** PPI network map of 11 pulmonary fibrosis-related upregulated genes with m^5^C gain. The color bar represents the mRNA log~2~ fold change between the two groups. **D.** RT-qPCR results showing the increased expression of four representative genes in lung samples from FA-exposed (bars in blue) and PM~2.5~-exposed (bars in watermelon red) mice. *P* values were determined using two-tailed Student's *t*-tests. \*, *P* \< 0.05; \*\*, *P* \< 0.01; \*\*\*, *P* \< 0.001. ADOPOQ, adiponectin, C1Q and collagen domain-containing; CHI3L1, chitinase-like 1; MMP9, matrix metallopeptidase 9; LCN2, lipocalin 2; ATPIF1, ATPase inhibitory factor 1; ATP5J2, ATP synthase, H^+^-transporting mitochondrial F0 complex subunit F2; ATP5L, ATP synthase, H^+^-transporting mitochondrial F0 complex subunit G; NDUFB6, NADH: ubiquinone oxidoreductase subunit B6; SLC11A1, solute carrier family 11; TYROBP, TYRO protein tyrosine kinase binding protein.

These observations are consistent with a previous report showing the important role of *Lcn2* and *Mmp9* in inflammation and fibrosis through the IL-17 signaling pathway ([Figure S4](#s0095){ref-type="sec"}) [@b0240], [@b0245]. IL-17 induces inflammation by activating fibroblasts, endothelial cells, and epithelial cells [@b0250]; it also enhances neutrophil recruitment to sites of inflammation [@b0255]. In the present study, upregulation of *Mmp9* and *Lcn2* expression through m^5^C gain upon PM~2.5~ exposure may be critical in m^5^C-mediated fibrosis. Furthermore, m^5^C modification is potentially implicated in the pathogenesis of PM~2.5~-induced pulmonary fibrosis.

Conclusion {#s0030}
==========

In this study, we report the first epitranscriptomic RNA m^5^C profile in PM~2.5~-induced pulmonary fibrosis. Our study offers insight into the relationship between PM~2.5~-induced pulmonary fibrosis and an altered mRNA m^5^C methylome. Moreover, mRNA m^5^C gain probably negatively affects normal metabolic activity, including RNA metabolism, oxidative stress responses, inflammatory responses, and immune system processes by upregulating gene expression levels in lungs of PM~2.5~-exposed mice. The results suggest that mRNA m^5^C modification may play a critical role in the pathogenesis of PM~2.5~-induced pulmonary fibrosis. Altogether, the results provides valuable evidence for elucidating the mechanism of PM~2.5~ exposure-related lung pathogenesis and identifying novel potential biomarkers.

Materials and methods {#s0035}
=====================

Experimental animals {#s0040}
--------------------

Four-week-old male C57BL/6 mice were purchased from Beijing Vital River Laboratory Animal Technology (Beijing, China). The mice were randomly assigned into the FA control group (*n* = 5) or PM~2.5~-exposed group (*n* = 5). Animals were either exposed to ambient PM~2.5~-polluted air or FA for 12 h/day, 7 days/week for 12 weeks (October 2017--January 2018) in a whole-body PM~2.5~ exposure system at the Zhongguancun Campus of the University of Chinese Academy of Sciences (UCAS), Beijing, China (N39°57′39.83″E116°20′10.97″). The exposure system included two separate chambers. In the FA chamber, ambient microparticles were removed by high-efficiency particulate air filter (Shanghai Liancheng Purification Equipment, Shanghai, China). In the PM~2.5~ chamber, ambient PM~2.5~ were collected with a swirler as previously reported [@b0260]. The PM~2.5~ levels in the chamber were continually monitored and sampled daily. During the exposure period, the animals were maintained in exposure chamber with 12 h light/dark cycle (temperature: 21 °C--22 °C; humidity: 40%--60%) and given standard laboratory chow and sterile deionized water *ad libitum*.

PM~2.5~ sampling and preparation {#s0045}
--------------------------------

To evaluate the PM~2.5~ levels in the PM~2.5~ chamber, ambient PM~2.5~ was sampled during the exposure period every day. The distance between the sampling inlets and the PM~2.5~ chamber was 30 m. The PM~2.5~ particles were collected by Teflon coated filters (diameter = 90 mm, Whatman, St. Louis, MO) with medium-volume samplers (TH-150D II, Tianhong, Wuhan, China) at 100 l/min flow rate for 12 h (08:00--20:00) every day. Before and after sampling, the filters were equilibrated for 48 h at 30% relative humidity and room temperature (25 °C). Then the filters were weighed for calculation of ambient PM~2.5~ levels. The sampled PM~2.5~ was extracted by sonication into deionized water (18 MΩ·cm) according to the method we reported previously [@b0265]. In brief, PM~2.5~ samples were sonicated for 0.5 h with the sonicator (Catalog No. KQ-700 V, Shumei, Kunshan, China). The PM~2.5~ suspension was stored at −80 °C prior to analysis.

The chemical properties of the PM~2.5~ were analyzed as described previously [@b0265]. Briefly, the metal elements were extracted by acid digestion (HNO~3~: HF = 7:3). Then the solution measured by inductively coupled plasma mass spectrometry (ICP-MS, Elemental X7, Thermo Fisher Scientific, Waltham, MA). The water-soluble inorganic components were measured with ion chromatography (Dionex-600, Thermo Fisher Scientific). Organic carbon (OC) and elemental carbon (EC) were determined by thermal-optical analyzer (Sunset Laboratories, Tigard, OR). The concentrations of metal elements, inorganic components, and carbon of the PM~2.5~ samples are listed in [Table S1](#s0095){ref-type="sec"}.

Tissue processing {#s0050}
-----------------

After exposing to PM~2.5~, mice were anesthetized and sacrificed. The lung tissues were fixed using 4% paraformaldehyde solution, then embedded in paraffin. Lung sections (6 μm) were stained by H&E (Catalog No. G1005, Wuhan Servicebio Technology, Wuhan, China) or with a Masson trichrome stain kit (Catalog No. DC0033, Beijing Leagene, Beijing, China).

Construction of the RNA-Seq and RNA-BisSeq libraries {#s0055}
----------------------------------------------------

Total RNA was extracted from mouse lungs with an RNAsimple Total RNA Kit (Catalog No. DP419, Tiangen, Beijing, China), and mRNA was isolated using a Dynabeads® mRNA Purification Kit (Catalog No.61006, Ambion, Waltham, MA). TURBO™ DNase (Catalog No. 61006, Ambion) treatment was used to eliminate DNA contamination at 37 °C for 30 min. Then, the mRNA was purified by ethanol precipitation. RNA extracted from the group of FA-exposed mice and that of PM~2.5~-exposed mice was pooled separately and used for construction of the RNA-Seq and RNA-BisSeq libraries.

The RNA-Seq libraries were constructed with a KAPA Stranded mRNA-Seq Kit (Catalog No. 07962207001, KAPA, Wilmington, MA). The RNA-BisSeq libraries were constructed based on the methods in a previous study with minor optimization [@b0100]. Briefly, *in vitro-* transcribed mouse *Dhfr* mRNA, a methylation conversion control, was mixed with approximately 200 ng of purified mRNA at a ratio of 1:300. Then, the RNA was fragmented into ∼100-nt fragments in 10× RNA Fragmentation Reagent (Catalog No. AM8740, Ambion) at 90 °C (1 min), which was terminated by 10× RNA stop solution (Catalog No. AM8740, Ambion). After precipitation with 100% ethanol, the RNA pellet was resuspended in 100 µl of a bisulfite solution containing a 100:1 mixture of 40% sodium bisulfite (Catalog No. 13438, Sigma, St. Louis, MO) and 600 µM hydroquinone (pH 5.1; catalog No. H9003, Sigma), and heat-incubated at 75 °C for 4.5 h. Nanosep columns with 3 K Omega membranes (Catalog No. OD003C35, PALL Corporation, Port Washington, NY) were used to desalt the reaction mixture with centrifugation. The RNA pellet was washed with nuclease-free water followed by centrifugation for five times. Finally, the RNA was re-suspended in 75 μl of nuclease-free water and then incubated at 75 °C for 1 h with equal volume of 1 M Tris-HCl (pH 9.0) for desulfonation. The RNA was dissolved in 11 µl of RNase-free water after ethanol precipitation. After reverse transcription with SuperScript II Reverse Transcriptase (Catalog No. 18064014, Invitrogen, Waltham, MA) and ACT random hexamers, a KAPA Stranded mRNA-Seq Kit (Catalog No. 07962207001, KAPA) was used to perform the subsequent procedures according to the manufacturer's instructions.

Quantitative real-time PCR {#s0060}
--------------------------

Total RNA was isolated with an RNAsimple Total RNA Kit (Catalog No. DP419, Tiangen). cDNA was synthesized using a GoScript Reverse Transcription System (Catalog No. A5001, Promega, Madison, WI) according to the manufacturer's instructions. The primer pairs used in this study are listed in [Table S5](#s0095){ref-type="sec"}. The gene expression levels were normalized to that of *ACTB*. RT-qPCR was performed as previously described [@b0270]. *P* values were determined using two-tailed Student's *t*-test. A difference with *P* \< 0.05 was defined as significant.

Western blotting analysis {#s0065}
-------------------------

Protein was extracted from the mouse lung tissues using RIPA lysis buffer containing PMSF (Catalog No. 97064-672, Amresco, Radnor, PA) and protease and phosphatase inhibitor cocktails (Catalog Nos. B14001 and B15001, Bimake, Houston, TX). The solution was centrifuged at 12,000*g* and 4 °C for 10 min, the supernatant was collected for further analysis. The expression of NSUN2 and β-actin in whole-cell lysates was analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Immunoreactive bands were detected with ECL reagents (Catalog No. 1705061, Bio-Rad, Berkeley, CA) according to the manufacturer's instructions. The following antibodies were used: rabbit anti-NSUN2 (Catalog No. 20854-1-AP, Proteintech, Wuhan, China) and mouse β-actin (Catalog No. AF0003, Beyotime, Shanghai, China).

Data analysis for high-throughput sequencing {#s0070}
--------------------------------------------

RNA-Seq and RNA-BisSeq were performed using an Illumina HiSeq 2500 platform with a paired-end read length of 150 bp. The adaptor sequences were trimmed off and low-quality bases were removed using Trimmomatic (version 0.33) [@b0275]. For RNA-Seq, the remaining reads with lengths greater than 35 nt were used for the alignment with the mouse reference genome (version mm10) with TopHat (version 2.1.1, default parameters) [@b0280]. Uniquely mapped reads (*q* ≥ 20) were used for the downstream analysis ([Table S2](#s0095){ref-type="sec"}). DEGs were detected with the DEGseq package in the R language [@b0285]. Genes with FC \> 1.2 and FDR \< 0.05 were defined as significantly up- or downregulated genes. For RNA-BisSeq, reads that contained more than three sequential Cs were removed to reduce the number of false positives [@b0290], [@b0295], and the resulting reads were then aligned to reference genomes with meRanT align (meRanTK version 1.2.0) [@b0300] with parameters: -fmo -mmr 0.01. The m^5^C sites were called by meRanCall (meRanTK, version 1.2.0) [@b0300] with parameters: -mBQ 20 -mr 0 and only sites with coverage depth ≥ 10, methylation level ≥ 0.1, methylated cytosine depth ≥ 2 were considered credible. BEDTools' intersectBed (version 2.26.0) [@b0305] was used to annotate the m^5^C sites. mRNAs with m^5^C gain or loss were defined as mRNAs that were specifically modified in the PM~2.5~ exposure or control samples. IGV (IGVTools, version 2.3.8) [@b0310] was used for visualization.

To explore the essential role of m^5^C modification in PM~2.5~-induced pulmonary fibrosis in mice, DEGs were separated into four groups based on m^5^C gain or loss and upregulation or downregulation of gene expression (FC \> 1.2, FDR \< 0.05). Only genes with reads per kilobase per million reads (RPKM) \>1 in at least one sample and mRNA with FC \> 1.5 were subjected to downstream analysis. The signaling network in lungs of mice exposed to PM~2.5~ was assessed with KEGG Mapper (<https://www.kegg.jp/kegg/mapper.html>). DAVID (version 6.8, <http://david.abcc.ncifcrf.gov/>) and Metascape (<http://metascape.org>) were used to perform GO analysis. GO terms with *P* \< 0.05 (hypergeometric test) were considered statistically significant ([Table S3](#s0095){ref-type="sec"}). DEGs from the four groups mentioned above were used to perform PPI network analysis. PPI network was generated using the Search Tool for the Retrieval of Interacting Genes (STRING) database [@b0315] ([Table S4](#s0095){ref-type="sec"}) and visualized with Cytoscape (version 3.6.0) [@b0320].

Promoter is defined as the region ±2 kb around the transcription start site [@b0225]. Prediction of TFs that potentially bind to the promoter sequence of *Nsun2*, was performed on <https://biogrid-lasagna.engr.uconn.edu/lasagna_search/>.
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Supplementary material {#s0095}
======================

The following are the Supplementary data to this article:Supplementary Figure S1**Distribution features of mRNA m^5^C in the lungs of FA and PM~2.5~-exposed mice A.** Heatmap illustrating the mRNA expression levels and m^5^C modification of several pulmonary fibrosis-related genes in the lung. The color bar represents the normalized RPKM of the genes. The blue and white boxes represent m^5^C-modified and unmodified genes, respectively. **B.** Pie chart showing the transcriptome-wide distribution of mRNA m^5^C sites. **C.** Sequence frequency logo for the sequences proximal to mRNA m^5^C sites (generated using WebLogo). **D.** RNA-BisSeq results revealing the numbers of m^5^C-modified mRNAs among different chromosomes. MT, mitochondria.

Supplementary Figure S2**PM~2.5~ exposure leads to altered gene expression in mouse lungs A.** Scatter plots showing the coverage of genes with m^5^C gain and loss in lung samples from FA-exposed and PM~2.5~-exposed mice. The Pearson correlation coefficient (R) is shown in the top left corner. **B.** Volcano plots displaying enrichment of DEGs in lung samples from PM~2.5~-exposed mice compared to FA-exposed mice. The numbers of upregulated (blue) or downregulated (purple) DEGs (FC \> 1.2, FDR \< 0.05) are shown. The vertical dashed lines indicate the FC cut-off (1.2), whereas the horizontal dashed lines indicate the FDR cut-off (0.05). **C.** Representative GO biological process categories enriched for the upregulated genes. **D.** Representative GO biological process categories enriched for the downregulated genes. The color bar represents the −log~10~*P* value.

Supplementary Figure S3**Bubble diagram of GO biological process categories enriched for DEGs with m^5^C gain or loss** The pink circle represents the −log~10~*P* value.

Supplementary Figure S4**Signaling network of m^5^C-modified Mmp9 and Lcn2 in pulmonary fibrosis mice** The network was produced using KEGG Mapper (). *Mmp9* and *Lcn2* were marked in red and yellow, respectively.
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